Cancer Risk Estimates Related to Susceptibility Genes (CARRIERS)

Request Access

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.

K. Lowry, H. Geuzinge, N. Stout, et al.. (2022). JAMA oncology. Cited 73 times. https://doi.org/10.1001/jamaoncol.2021.6204

Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk Score

Chi Gao, E. Polley, S. Hart, et al.. (2021). Journal of Clinical Oncology. Cited 68 times. https://doi.org/10.1200/JCO.20.01992

Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States.

S. Domchek, S. Yao, Fei Chen, et al.. (2021). JAMA oncology. Cited 28 times. https://doi.org/10.1001/jamaoncol.2021.1492

First international workshop of the ATM and cancer risk group (4-5 December 2019)

F. Lesueur, D. Easton, Anne-Laure Renault, et al.. (2021). Familial Cancer. Cited 18 times. https://doi.org/10.1007/s10689-021-00248-y
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747